News
WST ▲ +1.6% - West Pharmaceutical Services, Inc.
WST ▲ +1.6% - West Pharmaceutical Services, Inc.
$WST reported Q3 2026 Adj EPS of $2.66, beating the $2.19 estimate by 21.5%. Revenue of $874.5M beat the $826.4M estimate by 5.8%.
29-OCT-2026 06:14 AM ET
Share this post
More filings for $WST
WST ▲ +1.6% - West Pharmaceutical Services, Inc.Oct 29, 2026WST ▲ +1.1% - West Pharmaceutical Services, Inc.Oct 20, 2026WST ▲ +0.1% - West Pharmaceutical Services, Inc.Oct 19, 2026WST ▲ +0.0% - West Pharmaceutical Services, Inc.Oct 8, 2026WST ▼ -1.0% - West Pharmaceutical Services, Inc.Oct 1, 2026WST ▼ -0.8% - West Pharmaceutical Services, Inc.Oct 1, 2026
View full $WST filing history →💬 Comments
Loading comments…
Leave a comment